Trexquant Investment’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,267
| Closed | -$1.53M | – | 1656 |
|
|
2023
Q2 | $1.53M | Buy |
21,267
+4,916
| +30% | +$354K | 0.04% | 598 |
|
|
2023
Q1 | $1.2M | Sell |
16,351
-7,178
| -31% | -$528K | 0.03% | 658 |
|
|
2022
Q4 | $1.57M | Sell |
23,529
-1,693
| -7% | -$113K | 0.04% | 497 |
|
|
2022
Q3 | $1.36M | Buy |
25,222
+17,730
| +237% | +$953K | 0.05% | 447 |
|
|
2022
Q2 | $417K | Buy |
+7,492
| New | +$417K | 0.02% | 935 |
|
|
2022
Q1 | – | Sell |
-5,899
| Closed | -$568K | – | 1568 |
|
|
2021
Q4 | $568K | Buy |
+5,899
| New | +$568K | 0.04% | 580 |
|
|
2020
Q4 | – | Sell |
-10,597
| Closed | -$630K | – | 1281 |
|
|
2020
Q3 | $630K | Buy |
10,597
+1,777
| +20% | +$106K | 0.04% | 579 |
|
|
2020
Q2 | $615K | Sell |
8,820
-10,745
| -55% | -$749K | 0.04% | 588 |
|
|
2020
Q1 | $888K | Buy |
+19,565
| New | +$888K | 0.06% | 455 |
|
|
2019
Q4 | – | Sell |
-5,328
| Closed | -$331K | – | 1165 |
|
|
2019
Q3 | $331K | Sell |
5,328
-1,254
| -19% | -$77.9K | 0.03% | 584 |
|
|
2019
Q2 | $469K | Buy |
+6,582
| New | +$469K | 0.04% | 480 |
|
|
2019
Q1 | – | Sell |
-43,260
| Closed | -$3.66M | – | 1151 |
|
|
2018
Q4 | $3.66M | Buy |
43,260
+34,006
| +367% | +$2.88M | 0.23% | 126 |
|
|
2018
Q3 | $1.59M | Buy |
+9,254
| New | +$1.59M | 0.12% | 250 |
|
|
2015
Q2 | – | Sell |
-11,381
| Closed | -$547K | – | 1112 |
|
|
2015
Q1 | $547K | Sell |
11,381
-5,277
| -32% | -$254K | 0.06% | 652 |
|
|
2014
Q4 | $552K | Buy |
+16,658
| New | +$552K | 0.1% | 422 |
|